pravastatin has been researched along with Rhabdomyolysis in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (19.51) | 18.2507 |
2000's | 24 (58.54) | 29.6817 |
2010's | 9 (21.95) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL | 1 |
Chertow, GM; Erickson, KF; Garber, AM; Goldhaber-Fiebert, JD; Japa, S; Owens, DK | 1 |
Jha, V; Modi, GK | 1 |
Bailey, DG; Dixon, S; Fleet, JL; Gandhi, S; Garg, AX; Gomes, T; Juurlink, D; Kim, R; Li, DQ; Mamdani, M; McArthur, E; Shariff, SZ | 1 |
Florence, E; Kenyon, C; Leys, J; Suttels, V; Van den Ende, J; Vekemans, M; Vlieghe, E | 1 |
Cann, RC; Hurel, SJ; Laing, C; Marks, DJ | 1 |
Bachoumas, K; Fiancette, M; Lacherade, JC; Lascarrou, JB; Leclair, F; Reignier, J | 1 |
Glueck, CJ; Goldenberg, N; Khan, NA; Rawal, B; Wang, P; Yeramaneni, S | 1 |
Abel, T; Fehér, J | 1 |
Avigan, M; Barrett, JS; Brinker, AD; Chang, J; Mosholder, A; Nourjah, P; Rowan, C | 1 |
Cope, D; Iskander, E; Mikhail, N | 1 |
Bate, A; Edwards, IR; Hägg, S; Strandell, J | 1 |
Bouquié, R; Dailly, E; Deslandes, G; Haloun, A; Jolliet, P; Renaud, C | 1 |
Hildebrandt, GC; Panu, LD; Shahan, JL | 1 |
Bonnet, E; Breton, Y; Forestier, F; Janvier, G | 1 |
Gotto, AM | 1 |
Fischer, S; Haverich, A; Strüber, M; Walles, T; Wilhelmi, M; Winterhalter, M; Zuk, J | 1 |
Asaka, M; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Miura, T; Obara, S; Tanaka, J; Tsutsumi, Y; Yamato, H | 1 |
Phillips, PS | 1 |
Kakinuma, C; Naba, H; Ogihara, T; Ohnishi, S | 1 |
Biggs, MJ; Bonser, RS; Cram, R | 1 |
Komaroff, AL | 1 |
Alsheikh-Ali, AA; Karas, RH | 1 |
Kirch, W; Matschke, K; Schindler, C; Thorns, M; Tugtekin, SM | 1 |
Alsheikh-Ali, AA; Han, H; Karas, RH; Maddukuri, PV | 1 |
Dal Pan, G; McAdams, M; Staffa, J | 1 |
Bernstein, RL; Fischer, HD; Kagen, LJ; Neuwirth, MG; Rosenberg, AD; Singh, K | 1 |
Sirtori, CR | 1 |
de Groote, P; Decoulx, E; Ducloux, G; Mahieux, G; Millaire, A | 1 |
Stricker, BH; Wolterbeek, R | 1 |
Akama, H; Furuya, T; Hara, M; Hino, I; Kashiwazaki, S; Taniguchi, A; Ueda, H | 1 |
Wanner, C | 1 |
Chiba, S; Takei, A | 1 |
Garrido Sanjuán, JA; González González, C; Pía Iglesias, G; Sesma Sánchez, P | 1 |
Dunlay, R; Koch, M; Lund, RJ; Meares, AJ; Oldemeyer, JB | 1 |
Bottorff, M; Worz, CR | 1 |
Cohen, LH | 1 |
Bouhour, JB; Chevallier, JC; Le Marec, H; Raimondeau, J | 1 |
6 review(s) available for pravastatin and Rhabdomyolysis
Article | Year |
---|---|
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease.
Topics: Aged; Cost-Benefit Analysis; Decision Support Techniques; Disease Progression; Drug Costs; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Failure, Chronic; Male; Markov Chains; Myocardial Infarction; Pravastatin; Primary Prevention; Quality-Adjusted Life Years; Rhabdomyolysis; Risk; Sex Factors; Stroke; United States | 2013 |
Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.
Topics: Chemical and Drug Induced Liver Injury; Cholesterol, LDL; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Liver Diseases; Lovastatin; Neoplasms; Pravastatin; Rhabdomyolysis; Simvastatin | 2007 |
Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors.
Topics: Animals; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Rhabdomyolysis; Risk Factors; Simvastatin; Species Specificity; Structure-Activity Relationship; Tissue Distribution | 1993 |
[Rhabdomyolysis caused by pravastatin and type 1 macrocreatine kinase].
Topics: Creatine Kinase; Female; Humans; Hypercholesterolemia; Middle Aged; Pravastatin; Rhabdomyolysis | 1993 |
[Side effects of cholesterol synthesis inhibitors].
Topics: Aged; Anticholesteremic Agents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Male; Middle Aged; Pravastatin; Rhabdomyolysis; Simvastatin | 1993 |
The role of cytochrome P450-mediated drug-drug interactions in determining the safety of statins.
Topics: Aged; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Drug Interactions; Enzyme Inhibitors; Female; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Isoenzymes; Itraconazole; Lovastatin; Male; Middle Aged; Muscular Diseases; Pravastatin; Rhabdomyolysis; Simvastatin | 2001 |
1 trial(s) available for pravastatin and Rhabdomyolysis
Article | Year |
---|---|
Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
Topics: Atorvastatin; Cholesterol, LDL; Creatine Kinase; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lovastatin; Pravastatin; Prospective Studies; Pyrimidines; Pyrroles; Rhabdomyolysis; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2009 |
34 other study(ies) available for pravastatin and Rhabdomyolysis
Article | Year |
---|---|
Clinical features related to statin-associated muscle symptoms.
Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People | 2019 |
Cardiovascular disease: The price of a QALY--cost-effectiveness of statins in CKD.
Topics: Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Myocardial Infarction; Pravastatin; Rhabdomyolysis; Stroke | 2013 |
Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluorobenzenes; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperkalemia; Indoles; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pravastatin; Pyrimidines; Retrospective Studies; Rhabdomyolysis; Rosuvastatin Calcium; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides | 2015 |
A 68-year old male presenting with rhabdomyolysis-associated acute kidney injury following concomitant use of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate and pravastatin/fenofibrate: a case report.
Topics: Acute Kidney Injury; Aged; Anti-HIV Agents; Anticholesteremic Agents; Drug Interactions; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Fenofibrate; HIV Infections; Humans; Hypolipidemic Agents; Male; Pravastatin; Rhabdomyolysis | 2015 |
Acute kidney injury after Chernobyl.
Topics: Acute Kidney Injury; Chernobyl Nuclear Accident; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothyroidism; Male; Middle Aged; Pravastatin; Radiation Injuries; Rhabdomyolysis; Risk Factors; Severity of Illness Index; Thyroid Function Tests; Thyroxine; Time Factors | 2015 |
Fatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Biotransformation; Comorbidity; Cytochrome P-450 Enzyme System; Drug Interactions; Fatal Outcome; Fusidic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Osteitis; Pravastatin; Rhabdomyolysis; Staphylococcal Infections; Tibia | 2015 |
[Statin therapy and muscle disorders].
Topics: Atorvastatin; Biological Availability; Cytochrome P-450 Enzyme System; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Half-Life; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Muscle, Skeletal; Muscular Diseases; Pravastatin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2009 |
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Rhabdomyolysis; Risk Assessment; Risk Factors; Simvastatin; Young Adult | 2009 |
Rhabdomyolysis in an HIV-infected patient on anti-retroviral therapy precipitated by high-dose pravastatin.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Deoxycytidine; Dyslipidemias; Emtricitabine; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Oligopeptides; Organophosphonates; Pravastatin; Pyridines; Rhabdomyolysis; Ritonavir; Tenofovir | 2009 |
Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Atorvastatin; Azithromycin; Databases, Factual; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Pravastatin; Pyridines; Pyrroles; Rhabdomyolysis; Simvastatin | 2009 |
Colchicine-induced rhabdomyolysis in a heart/lung transplant patient with concurrent use of cyclosporin, pravastatin, and azithromycin.
Topics: Adult; Anti-Bacterial Agents; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azithromycin; Colchicine; Cyclosporine; Cystic Fibrosis; Drug Interactions; Gout; Gout Suppressants; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Multiple Organ Failure; Pravastatin; Rhabdomyolysis | 2011 |
Rhabdomyolysis in a multiple myeloma patient secondary to concurrent treatment with lenalidomide and pravastatin and to lenalidomide alone.
Topics: Amines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Boronic Acids; Bortezomib; Combined Modality Therapy; Creatine Kinase, MM Form; Cyclohexanecarboxylic Acids; Dexamethasone; Drug Synergism; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunologic Factors; Kidney Diseases; Lenalidomide; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Polyneuropathies; Pravastatin; Pyrazines; Rhabdomyolysis; Thalidomide | 2012 |
The HMG Co-A reductase inhibitors ('statins') and myotoxic effects.
Topics: Atorvastatin; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Muscular Diseases; Myositis; Pravastatin; Pyrroles; Rhabdomyolysis; Simvastatin | 2002 |
Severe rhabdomyolysis after laparoscopic surgery for adenocarcinoma of the rectum in two patients treated with statins.
Topics: Adenocarcinoma; Creatine Kinase; Creatinine; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Laparoscopy; Male; Middle Aged; Paralysis; Postoperative Complications; Pravastatin; Rectal Neoplasms; Rectum; Rhabdomyolysis | 2002 |
Muscular adverse effects of statins.
Topics: Anticholesteremic Agents; Fatty Acids, Monounsaturated; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Pravastatin; Pyridines; Pyrroles; Rhabdomyolysis; Simvastatin | 2003 |
Safety and statin therapy: reconsidering the risks and benefits.
Topics: Anticholesteremic Agents; Creatine Kinase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Meta-Analysis as Topic; Muscular Diseases; Pravastatin; Pyridines; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyolysis; Transaminases; Treatment Outcome | 2003 |
Massive postoperative rhabdomyolysis following combined CABG/abdominal aortic replacement: a possible association with HMG-CoA reductase inhibitors.
Topics: Acute Kidney Injury; Aged; Aorta, Abdominal; Coronary Artery Bypass; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Myoglobinuria; Postoperative Complications; Pravastatin; Rhabdomyolysis | 2002 |
Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins.
Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus; Drug Evaluation; Heptanoic Acids; Humans; Hypertension; Pravastatin; Pyrroles; Rhabdomyolysis; Simvastatin; Stroke; Treatment Outcome | 2003 |
Rhabdomyolysis caused by distigmine bromide.
Topics: Aged; Anticholesteremic Agents; Cholestyramine Resin; Drug Interactions; Female; Humans; Muscle, Skeletal; Pravastatin; Pyridinium Compounds; Rhabdomyolysis; Urinary Retention | 2003 |
How common is rhabdomyolysis in patients receiving lipid-lowering therapy?
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Biomarkers; Creatine Kinase; Drug Therapy, Combination; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Incidence; Middle Aged; Pravastatin; Pyrroles; Retrospective Studies; Rhabdomyolysis; Risk Factors; Simvastatin; United States | 2005 |
Improving effect of ethyl eicosapentanoate on statin-induced rhabdomyolysis in Eisai hyperbilirubinemic rats.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbilirubinemia; Muscle, Skeletal; Platelet Aggregation Inhibitors; Pravastatin; Rats; Rhabdomyolysis; Severity of Illness Index; Treatment Outcome | 2006 |
Localized rhabdomyolysis after exertion in a cardiac transplant recipient on statin therapy.
Topics: Adult; Arm; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Physical Exertion; Pravastatin; Rhabdomyolysis; Weight Lifting | 2006 |
By the way, doctor. I take Pravachol to control my cholesterol, and because of high triglycerides, my doctor wants to add TriCor. But my pharmacist warns against taking both medications. If I don't take TriCor, are there alternatives?
Topics: Drug Interactions; Fenofibrate; Humans; Hypolipidemic Agents; Liver; Pravastatin; Rhabdomyolysis | 2005 |
Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
Topics: Adverse Drug Reaction Reporting Systems; Atorvastatin; Chemical and Drug Induced Liver Injury; Drug Prescriptions; Drug Therapy, Combination; Dyslipidemias; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver Diseases; Lovastatin; Niacin; Pravastatin; Prevalence; Pyrroles; Retrospective Studies; Rhabdomyolysis; Risk Factors; Simvastatin; United States; United States Food and Drug Administration | 2007 |
Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin.
Topics: Acute Disease; Aged; Creatine Kinase; Dyspnea; Heart Transplantation; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Cells; Pravastatin; Probability; Rhabdomyolysis; Time Factors | 2007 |
Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Atorvastatin; Child; Child, Preschool; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Infant; Male; Middle Aged; Pravastatin; Pyridines; Pyrroles; Retrospective Studies; Rhabdomyolysis; Simvastatin; United States; United States Food and Drug Administration | 2008 |
Intraoperative rhabdomyolysis in a patient receiving pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor.
Topics: Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Mitochondria, Muscle; Myoglobinuria; Pravastatin; Rhabdomyolysis; Spine | 1995 |
Pravastatin-induced rhabdomyolysis in a patient with mixed connective tissue disease.
Topics: Enzyme Inhibitors; Female; Humans; Middle Aged; Mixed Connective Tissue Disease; Pravastatin; Rhabdomyolysis | 1996 |
HMG-CoA reductase inhibitor treatment in renal insufficiency.
Topics: Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Lovastatin; Pravastatin; Rhabdomyolysis; Simvastatin | 1996 |
Rhabdomyolysis associated with pravastatin treatment for major depression.
Topics: Aged; Anticholesteremic Agents; Antidepressive Agents; Depressive Disorder, Major; Drug Interactions; Female; Humans; Hypercholesterolemia; Pravastatin; Rhabdomyolysis | 1999 |
[Antilipemic agents, hypothyroidism, and rhabdomyolysis].
Topics: Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; Middle Aged; Pravastatin; Rhabdomyolysis | 2000 |
Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations.
Topics: Acute Kidney Injury; Aged; Coronary Disease; Drug Therapy, Combination; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Pravastatin; Rhabdomyolysis; Simvastatin | 2000 |
[Myotoxicity and rhabdomyolisis due to statins].
Topics: Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscles; Pravastatin; Pyridines; Rhabdomyolysis | 2002 |
[Biological myolysis during combined fenofibrate-pravastatin therapy].
Topics: Angina Pectoris; Creatine Kinase; Drug Therapy, Combination; Fenofibrate; Humans; Male; Middle Aged; Pravastatin; Rhabdomyolysis | 1992 |